MEMANTINA TEVA

Informazioni principali

  • Nome commerciale:
  • MEMANTINA TEVA
  • Utilizzare per:
  • Esseri umani
  • Tipo di medicina:
  • Farmaco allopatico

Documenti

  • per il pubblico:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per il pubblico.

  • per i professionisti:
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.


    Richiedi il foglio illustrativo per i professionisti.

Localizzazione

  • Disponibile in:
  • MEMANTINA TEVA
    Italia
  • Lingua:
  • italiano

Informazioni terapeutiche

  • Area terapeutica:
  • Memantina
  • Dettagli prodotto:
  • 043176027 - "10 MG COMPRESSE RIVESTITE CON FILM" 100 COMPRESSE IN FLACONE HDPE - revocato; 043176015 - "10 MG COMPRESSE RIVESTITE CON FILM" 180X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176041 - "10 MG COMPRESSE RIVESTITE CON FILM" 200 COMPRESSE IN FLACONE HDPE - revocato; 043176825 - "20 MG COMPRESSE RIVESTITE CON FILM " 14 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176837 - "20 MG COMPRESSE RIVESTITE CON FILM " 14X1 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176849 - "20 MG COMPRESSE RIVESTITE CON FILM " 20 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176852 - "20 MG COMPRESSE RIVESTITE CON FILM " 20X1 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176864 - "20 MG COMPRESSE RIVESTITE CON FILM " 21 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176876 - "20 MG COMPRESSE RIVESTITE CON FILM " 21X1 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176888 - "20 MG COMPRESSE RIVESTITE CON FILM " 28 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176902 - "20 MG COMPRESSE RIVESTITE CON FILM " 28 COMPRESSE IN BLISTER PVC/PVDC/AL CONFEZIONE CALENDARIO - revocato; 043176890 - "20 MG COMPRESSE RIVESTITE CON FILM " 28X1 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176914 - "20 MG COMPRESSE RIVESTITE CON FILM " 28X1 COMPRESSE IN BLISTER PVC/PVDC/AL CONFEZIONE CALENDARIO - revocato; 043176926 - "20 MG COMPRESSE RIVESTITE CON FILM " 30 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176938 - "20 MG COMPRESSE RIVESTITE CON FILM " 30X1 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176940 - "20 MG COMPRESSE RIVESTITE CON FILM " 42 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176953 - "20 MG COMPRESSE RIVESTITE CON FILM " 42X1 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176965 - "20 MG COMPRESSE RIVESTITE CON FILM " 50 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176977 - "20 MG COMPRESSE RIVESTITE CON FILM " 50X1 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176989 - "20 MG COMPRESSE RIVESTITE CON FILM " 50X1 COMPRESSE IN BLISTER PVC/PVDC/AL CONFEZIONE OSPEDALIERA - revocato; 043176991 - "20 MG COMPRESSE RIVESTITE CON FILM " 56 COMPRESSE IN BLISTER PVC/PVDC/AL - revocato; 043176357 - "20 MG COMPRESSE RIVESTITE CON FILM" 100 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176724 - "20 MG COMPRESSE RIVESTITE CON FILM" 100 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176066 - "20 MG COMPRESSE RIVESTITE CON FILM" 100 COMPRESSE IN FLACONE HDPE - revocato; 043176369 - "20 MG COMPRESSE RIVESTITE CON FILM" 100X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176736 - "20 MG COMPRESSE RIVESTITE CON FILM" 100X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176371 - "20 MG COMPRESSE RIVESTITE CON FILM" 112 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176748 - "20 MG COMPRESSE RIVESTITE CON FILM" 112 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176383 - "20 MG COMPRESSE RIVESTITE CON FILM" 112X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176751 - "20 MG COMPRESSE RIVESTITE CON FILM" 112X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176395 - "20 MG COMPRESSE RIVESTITE CON FILM" 120 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176763 - "20 MG COMPRESSE RIVESTITE CON FILM" 120 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176407 - "20 MG COMPRESSE RIVESTITE CON FILM" 120X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176775 - "20 MG COMPRESSE RIVESTITE CON FILM" 120X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176080 - "20 MG COMPRESSE RIVESTITE CON FILM" 14 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176458 - "20 MG COMPRESSE RIVESTITE CON FILM" 14 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176092 - "20 MG COMPRESSE RIVESTITE CON FILM" 14X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176460 - "20 MG COMPRESSE RIVESTITE CON FILM" 14X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176419 - "20 MG COMPRESSE RIVESTITE CON FILM" 168 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176787 - "20 MG COMPRESSE RIVESTITE CON FILM" 168 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176421 - "20 MG COMPRESSE RIVESTITE CON FILM" 168X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176799 - "20 MG COMPRESSE RIVESTITE CON FILM" 168X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176433 - "20 MG COMPRESSE RIVESTITE CON FILM" 180 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176801 - "20 MG COMPRESSE RIVESTITE CON FILM" 180 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176445 - "20 MG COMPRESSE RIVESTITE CON FILM" 180X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176813 - "20 MG COMPRESSE RIVESTITE CON FILM" 180X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176104 - "20 MG COMPRESSE RIVESTITE CON FILM" 20 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176472 - "20 MG COMPRESSE RIVESTITE CON FILM" 20 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176078 - "20 MG COMPRESSE RIVESTITE CON FILM" 200 COMPRESSE IN FLACONE HDPE - revocato; 043176116 - "20 MG COMPRESSE RIVESTITE CON FILM" 20X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176484 - "20 MG COMPRESSE RIVESTITE CON FILM" 20X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176128 - "20 MG COMPRESSE RIVESTITE CON FILM" 21 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176496 - "20 MG COMPRESSE RIVESTITE CON FILM" 21 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176130 - "20 MG COMPRESSE RIVESTITE CON FILM" 21X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176508 - "20 MG COMPRESSE RIVESTITE CON FILM" 21X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176142 - "20 MG COMPRESSE RIVESTITE CON FILM" 28 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176167 - "20 MG COMPRESSE RIVESTITE CON FILM" 28 COMPRESSE IN BLISTER PA/AL/PVC/AL CONFEZIONE CALENDARIO - revocato; 043176510 - "20 MG COMPRESSE RIVESTITE CON FILM" 28 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176534 - "20 MG COMPRESSE RIVESTITE CON FILM" 28 COMPRESSE IN BLISTER PVC/PE/PVDC/AL CONFEZIONE CALENDARIO - revocato; 043176155 - "20 MG COMPRESSE RIVESTITE CON FILM" 28X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176179 - "20 MG COMPRESSE RIVESTITE CON FILM" 28X1 COMPRESSE IN BLISTER PA/AL/PVC/AL CONFEZIONE CALENDARIO - revocato; 043176522 - "20 MG COMPRESSE RIVESTITE CON FILM" 28X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176546 - "20 MG COMPRESSE RIVESTITE CON FILM" 28X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL CONFEZIONE CALENDARIO - revocato; 043176181 - "20 MG COMPRESSE RIVESTITE CON FILM" 30 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176559 - "20 MG COMPRESSE RIVESTITE CON FILM" 30 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176054 - "20 MG COMPRESSE RIVESTITE CON FILM" 30 COMPRESSE IN FLACONE HDPE - revocato; 043176193 - "20 MG COMPRESSE RIVESTITE CON FILM" 30X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176561 - "20 MG COMPRESSE RIVESTITE CON FILM" 30X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176205 - "20 MG COMPRESSE RIVESTITE CON FILM" 42 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176573 - "20 MG COMPRESSE RIVESTITE CON FILM" 42 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176217 - "20 MG COMPRESSE RIVESTITE CON FILM" 42X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176585 - "20 MG COMPRESSE RIVESTITE CON FILM" 42X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176229 - "20 MG COMPRESSE RIVESTITE CON FILM" 50 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176597 - "20 MG COMPRESSE RIVESTITE CON FILM" 50 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176231 - "20 MG COMPRESSE RIVESTITE CON FILM" 50X1 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176243 - "20 MG COMPRESSE RIVESTITE CON FILM" 50X1 COMPRESSE IN BLISTER PA/AL/PVC/AL CONFEZIONE OSPEDALIERA - revocato; 043176609 - "20 MG COMPRESSE RIVESTITE CON FILM" 50X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL - revocato; 043176611 - "20 MG COMPRESSE RIVESTITE CON FILM" 50X1 COMPRESSE IN BLISTER PVC/PE/PVDC/AL CONFEZIONE OSPEDALIERA - revocato; 043176256 - "20 MG COMPRESSE RIVESTITE CON FILM" 56 COMPRESSE IN BLISTER PA/AL/PVC/AL - revocato; 043176270 - "20 MG COMPRESSE RIVESTITE CON FILM" 56 COMPRESSE IN BLISTER PA/AL/PVC/AL CONFEZIONE CALENDARIO - revocato; 043176623 - "2

Altre informazioni

Status

  • Fonte:
  • AIFA - Agenzia Italiana del Farmaco
  • Numero dell'autorizzazione:
  • 043176
  • Ultimo aggiornamento:
  • 06-01-2018
  • Il foglio illustrativo per questo prodotto non è al momento disponibile, é possibile inviare una richiesta al nostro Servizio Clienti ed essere avvisati nel momento in cui è disponibile sulla nostra piattaforma.

    Richiedi il foglio illustrativo per il pubblico.

21-12-2018

One lot of Equate brand Lens Care System and Multi-Purpose Solution voluntarily recalled because of a labelling error

One lot of Equate brand Lens Care System and Multi-Purpose Solution voluntarily recalled because of a labelling error

Teva Canada is voluntarily recalling one lot (Lot 150261) of two products because of a labelling error. While the outer carton of Equate brand Lens Care System is correctly labelled, the bottle within the carton is mislabelled as Equate brand Multi-Purpose Solution. Because of the labelling error, the company is recalling both products labelled with Lot 150261. Bottles labelled as Equate Multi-Purpose Solution should contain a 0.0001% w/v polyhexanide based disinfecting solution for rinsing. The mislabel...

Health Canada

17-12-2018

Teva Canada Product Recall (2018-12-17)

Teva Canada Product Recall (2018-12-17)

Health Canada

27-11-2018

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets That Are Within Expiry

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of All Amlodipine/Valsartan Combination Tablets and Amlodipine/Valsartan/Hydrochlorothiazide Combination Tablets That Are Within Expiry

Teva Pharmaceuticals has initiated a voluntary recall in the United States, to the patient level, of all lots of Amlodipine / Valsartan combination tablets and Amlodipine / Valsartan / Hydrochlorothiazide combination tablets (see table below) due to an impurity detected above specification limits in an active pharmaceutical ingredient (API) manufactured by Mylan India. The impurity found in Mylan’s valsartan API is known as N-nitroso-diethylamine (NDEA), which has been classified as a probable human carc...

FDA - U.S. Food and Drug Administration

23-11-2018

Teva Canada Product Recall (2018-11-23)

Teva Canada Product Recall (2018-11-23)

Health Canada

17-7-2018

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets

Teva Pharmaceuticals USA Issues Voluntary Nationwide Recall of Valsartan and Valsartan Hydrochlorothiazide Tablets

Teva Pharmaceuticals USA today confirmed a voluntary recall to the consumer / user level of 29 lots of single and 51 lots of combination valsartan medicines distributed under the Actavis label in the U.S. due to the detection of trace amounts of an unexpected impurity found in an active pharmaceutical ingredient (API) manufactured by Zhejiang Huahai Pharmaceutical. The impurity detected in the API is N- nitrosodimethylamine (NDMA), which is a substance that occurs naturally in certain foods, drinking wat...

FDA - U.S. Food and Drug Administration

16-7-2018

Major Pharmaceuticals Issues Voluntary Nationwide Recall of Valsartan Due to The Potential Presence of a Probable Carcinogen (NDMA)

Major Pharmaceuticals Issues Voluntary Nationwide Recall of Valsartan Due to The Potential Presence of a Probable Carcinogen (NDMA)

As a precautionary measure, the distribution firm, Major Pharmaceuticals, is issuing a nationwide voluntary recall of all lots within expiry of Valsartan which were supplied by Teva Pharmaceuticals and labeled as Major Pharmaceuticals.

FDA - U.S. Food and Drug Administration

14-12-2018

Desloratadine Teva (Teva B.V.)

Desloratadine Teva (Teva B.V.)

Desloratadine Teva (Active substance: desloratadine) - Centralised - Yearly update - Commission Decision (2018)8912 of Fri, 14 Dec 2018

Europe -DG Health and Food Safety

30-11-2018

Pioglitazone Teva (Teva B.V.)

Pioglitazone Teva (Teva B.V.)

Pioglitazone Teva (Active substance: pioglitazone) - Centralised - Yearly update - Commission Decision (2018)8159 of Fri, 30 Nov 2018

Europe -DG Health and Food Safety

30-11-2018

Pioglitazone Teva Pharma (Teva B.V.)

Pioglitazone Teva Pharma (Teva B.V.)

Pioglitazone Teva Pharma (Active substance: pioglitazone) - Centralised - Yearly update - Commission Decision (2018)8158 of Fri, 30 Nov 2018

Europe -DG Health and Food Safety

26-11-2018

Kentera (Teva B.V.)

Kentera (Teva B.V.)

Kentera (Active substance: Oxybutynin) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)7967 of Mon, 26 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/532/T/49

Europe -DG Health and Food Safety

14-11-2018

Clopidogrel ratiopharm (Teva B.V.)

Clopidogrel ratiopharm (Teva B.V.)

Clopidogrel ratiopharm (Active substance: clopidogrel) - Centralised - Yearly update - Commission Decision (2018)7602 of Wed, 14 Nov 2018

Europe -DG Health and Food Safety

22-10-2018

Irbesartan / Hydrochlorothiazide Teva (Teva B.V.)

Irbesartan / Hydrochlorothiazide Teva (Teva B.V.)

Irbesartan / Hydrochlorothiazide Teva (Active substance: irbesartan / hydrochlorothiazide) - Centralised - Yearly update - Commission Decision (2018) 6974 of Mon, 22 Oct 2018

Europe -DG Health and Food Safety

2-10-2018

Lamivudine Teva Pharma B.V. (Teva B.V.)

Lamivudine Teva Pharma B.V. (Teva B.V.)

Lamivudine Teva Pharma B.V. (Active substance: Lamivudine) - Centralised - Yearly update - Commission Decision (2018)6476 of Tue, 02 Oct 2018

Europe -DG Health and Food Safety

2-10-2018

Docetaxel Teva (Teva B.V.)

Docetaxel Teva (Teva B.V.)

Docetaxel Teva (Active substance: Docetaxel) - Centralised - Yearly update - Commission Decision (2018)6463 of Tue, 02 Oct 2018

Europe -DG Health and Food Safety

2-10-2018

Zoledronic acid Teva (Teva B.V.)

Zoledronic acid Teva (Teva B.V.)

Zoledronic acid Teva (Active substance: zoledronic acid) - Centralised - Yearly update - Commission Decision (2018)6466 of Tue, 02 Oct 2018

Europe -DG Health and Food Safety

24-9-2018

Cinqaero (Teva B.V.)

Cinqaero (Teva B.V.)

Cinqaero (Active substance: reslizumab) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)6218 of Mon, 24 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/3912T/18

Europe -DG Health and Food Safety

19-9-2018

Memantine Mylan (Mylan S.A.S.)

Memantine Mylan (Mylan S.A.S.)

Memantine Mylan (Active substance: Memantine) - Centralised - Transfer Marketing Authorisation Holder - Commission Decision (2018)5972 of Wed, 19 Sep 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2660/T/12

Europe -DG Health and Food Safety

7-8-2018

Memantine Accord (Accord Healthcare Limited)

Memantine Accord (Accord Healthcare Limited)

Memantine Accord (Active substance: memantine) - Centralised - Renewal - Commission Decision (2018)5421 of Tue, 07 Aug 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2766/R/10

Europe -DG Health and Food Safety

1-8-2018

Temozolomide Teva (Teva B.V.)

Temozolomide Teva (Teva B.V.)

Temozolomide Teva (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2018)5214 of Wed, 01 Aug 2018

Europe -DG Health and Food Safety

30-7-2018

Rasagiline ratiopharm (Teva B.V.)

Rasagiline ratiopharm (Teva B.V.)

Rasagiline ratiopharm (Active substance: rasagiline) - Centralised - Yearly update - Commission Decision (2018)5108 of Mon, 30 Jul 2018

Europe -DG Health and Food Safety

18-5-2018

Ovaleap (Teva B.V.)

Ovaleap (Teva B.V.)

Ovaleap (Active substance: Follitropin alfa) - Centralised - Renewal - Commission Decision (2018)3154 of Fri, 18 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/2608/R/23

Europe -DG Health and Food Safety

15-5-2018

Imatinib Teva B.V. (Teva B.V.)

Imatinib Teva B.V. (Teva B.V.)

Imatinib Teva B.V. (Active substance: imatinib) - Centralised - Withdrawal - Commission Decision (2018)3008 of Tue, 15 May 2018

Europe -DG Health and Food Safety

15-5-2018

Effentora (Teva B.V.)

Effentora (Teva B.V.)

Effentora (Active substance: fentanyl citrate) - PSUSA - Modification - Commission Decision (2018)3013 of Tue, 15 May 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/PSUSA/1369/201704

Europe -DG Health and Food Safety

3-5-2018

Pramipexole Teva (Teva B.V.)

Pramipexole Teva (Teva B.V.)

Pramipexole Teva (Active substance: pramipexole) - Centralised - Yearly update - Commission Decision (2018)2775 of Thu, 03 May 2018

Europe -DG Health and Food Safety

3-5-2018

Trisenox (Teva B.V.)

Trisenox (Teva B.V.)

Trisenox (Active substance: Arsenic trioxide) - Centralised - Yearly update - Commission Decision (2018)2778 of Thu, 03 May 2018

Europe -DG Health and Food Safety